Brendan Digan
Stock Analyst at Citi
(2.55)
# 2,964
Out of 5,078 analysts
6
Total ratings
66.7%
Success rate
36.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Brendan Digan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Reiterated: Buy | $315 → $365 | $403.95 | -9.64% | 3 | Aug 14, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $45 | $50.39 | -10.70% | 1 | Aug 10, 2026 | |
| SHC Sotera Health Company | Reiterated: Buy | $25 | $18.10 | +38.12% | 1 | Aug 7, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $50 | $71.55 | -30.12% | 1 | Aug 7, 2026 |
Natera
Aug 14, 2026
Reiterated: Buy
Price Target: $315 → $365
Current: $403.95
Upside: -9.64%
Qiagen
Aug 10, 2026
Reiterated: Hold
Price Target: $45
Current: $50.39
Upside: -10.70%
Sotera Health Company
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $18.10
Upside: +38.12%
10x Genomics
Aug 7, 2026
Reiterated: Hold
Price Target: $50
Current: $71.55
Upside: -30.12%